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 Introduction  
 Systemic granulomas develop in re-
sponse to infections like  Mycobacterium 
tuberculosis and  Schistosoma mansoni , to 
foreign material or in the context of non-
infectious diseases like sarcoidosis and 
granulomatosis with polyangiitis (Wegen-
er’s granulomatosis). Cutaneous granulo-
mas with unknown aetiology not related 
to infectious or systemic diseases occur 
uncommonly in various primary immu-
nodeficiencies (PIDs).
 Ataxia telangiectasia (A-T) is caused by 
a mutation in the  A-T Mutated gene, local-
ized on chromosome 11 (11q22–23), and its 
protein is involved in cell cycle control and 
DNA repair  [1] . A-T is characterized by 
progressive cerebellar ataxia, oculocuta-
neous telangiectasia, immunodeficiency, 
predisposition toward malignancy, elevat-
ed   1 -fetoprotein levels, rearrangement of 
chromosome 7 and 14, and increased ra-
diosensitivity. In addition, A-T patients 
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 Abstract 
 Background: Non-infective cutaneous 
granulomas with unknown pathogenesis 
occur in various primary immunodeficien-
cies (PIDs) including ataxia telangiectasia
(A-T).  Objective: To find a common immuno-
logical denominator in these cutaneous 
granulomas.  Methods: The dermatological 
and immunological features of 4 patients 
with A-T and cutaneous granulomas were 
described. The literature on skin granulomas 
in A-T and in other PIDs is reviewed.  Results: 
All 4 A-T patients had progressive granulo-
mas on their limbs and showed decreased 
IgG and IgA concentrations with normal IgM 
levels. They had a marked decrease in B cells 
and naïve T cells coinciding with the appear-
ance of the cutaneous granulomas. Similar 
B- and T-cell abnormalities were described 
in patients with other PIDs with skin granu-
lomas.  Conclusions: We hypothesize that 
the pathogenesis of these skin granulomas 
is related to immune dysregulation of mac-
rophages due to the absence of naïve T cells 
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may display a wide range of humoral and 
cellular immune system abnormalities 
and variable lymphopenia  [2] . Here we de-
scribe 4 A-T patients who developed cuta-
neous granulomas and review the litera-
ture of all (n = 17) reported A-T patients 
with skin granulomas. In addition, we re-
view the literature on cutaneous granulo-
mas in all known other PIDs. Based on
the obtained data we propose that unex-
plained cutaneous granulomas in PID pa-
tients can be considered as a manifestation 
of dysregulation in wound healing and tis-
sue repair explained by the immune de-
fects inherent in these PIDs.
 Patients and Methods 
 In mid-2010 there were 52 patients 
known in the Dutch A-T registry. In all, 
the diagnosis was confirmed by chromo-
somal analysis. Cutaneous granulomas 
developed in 4 (8%) of these 52 patients. 
Unfortunately, 1 patient was lost to follow-
up. In this article, we discuss the 3 Dutch 
A-T patients and include 1 Icelandic A-T 
patient with cutaneous granulomas who 
shared the same immunological profile. 
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the  ATM  gene ( table 1 ) without ATM ki-
nase activity. We also reviewed the exist-
ing literature on cutaneous granulomata 
in patients with A-T and in patients with 
other PIDs. To this end a search was done 
in PubMed with the MeSH words ‘granu-
loma’, ‘skin’, ‘cutaneous’ and all known 
PIDs as reported by the International 
Union of Immunological Societies Expert 
Committee on Primary Immunodeficien-
cies  [3] . Included were all primary publica-
tions published in English, German and 
French. Ten primary reports were found 
describing cutaneous granulomas in A-T 
 [4–13] and a series of articles reporting 
skin granulomas in other PIDs  [14–26] . 
For common variable immunodeficiency 
(CVID), often associated with granulomas 
in various organs, only the recently pub-
lished article of Ardeniz and Cunning-
ham-Rundles  [23] dealing with skin gran-
ulomas was included.
 Case Reports 
 Patient 1 
 An 8-year-old girl of Moroccan ances-
try presented with a 1-year history of ten-
der lesions on the left leg appearing after a 
fall. It started as an ulcer, which progres-
sively enlarged to involve her entire lower 
leg. She had had a diagnosis of A-T at
2 years of age on the basis of cerebellar 
ataxia, elevated   -fetoprotein, recurrent 
sinopulmonary infections with low IgG, 
deficient IgA ( ! 0.10 g/l) but normal IgM 
(1.18 g/l;  table 1 ). At the time of appearance 
of the granulomas, she had almost ab-
sent CD19+ B cells, extremely low naïve 
(CD3+CD4+C45RA+) T cells and normal 
natural killer (NK) cells in her peripheral 
blood ( table  1 ). Clinical examination re-
vealed multiple tender ulcers on the left 
anterior shin and below her knee. The ul-
cers had irregular ragged edges with clean 
fibrinous bases. The surrounding skin was 
erythematous, atrophic and had surface 
telangiectasia ( fig. 1 ). A biopsy from the le-
sions showed palisading granulomas con-
sisting of histiocytes and polynuclear gi-
ant cells with necrosis. Alcian blue stain, 
Ziehl-Neelsen and periodic acid-Schiff 
stain were negative as were cultures for mi-
cro-organisms. The lesions continued to 
deteriorate despite topical tacrolimus, top-
ical corticosteroids, oral antibiotics, tuber-
culostatics and increment of the dosage of 
intravenous immunoglobulin. Slight im-
provement was noted when she was on oral 
corticosteroids given for her interstitial 
lung disease. She suffered from recurrent 
chest infection and succumbed due to re-
spiratory failure at 14 years of age.
 Patient 2 
 Patient 2, the son of consanguineous 
Dutch parents, was diagnosed as having 
Table 1. I mmunological characteristics of the 4 described A-T patients with skin granulomas at the time of diagnosis of A-T and of 
granulomas
Normal value Patient 1 Patient 2 Patient 3 Patient 4
At the time of diagnosis of A-T
Age, months 24 24 12 24
Mutation c.2921+5G]A c.2467+1551 del 97kb c.5188C]T c.2554C]T
IgG, g/l 4.0–11.0 2.27 2.34 0.50 0.30
IgA, g/l 0.1–1.80 <0.10 <0.10 <0.10 <0.10
IgM, g/l 0.5–1.80 1.18 1.93 0.90 0.83
CD19+ B cells, !109/l 9–15 months: 0.6–2.7 
15–24 months: 0.6–3.1
0.4 0.16 0.16 0.07
CD3+ T cells, !109/l 9–15 months: 1.6–6.7
15–24 months: 1.4–8.0
1.6 0.83 1.04 0.68
CD4+ T cells, !109/l 9–15 months: 1.0–4.6
15–24 months: 0.9–5.5
1.0 0.72 0.45 0.30
Naïve CD4+ T cells, !109/l 0.4 0.10 0.02 not available
Effector CD4+ T cells, !109/l 1.0 0.57 0.40 not available
CD8+ T cells, !109/l 9–15 months: 1.0–4.6
15–24 months: 0.9–5.5
1.2 0.21 0.21 0.56
NK cells, !109/l 9–15 months: 0.2–1.2
15–24 months: 0.1–1.4
1.1 0.15 0.50 0.51
At the time of diagnosis of granulomas
Age, years 8 8 7 8
B cells, !109/l 0.2–1.6 0.01 0.03 0.07 0.01
CD3+ T cells, !109/l 0.7–4.2 0.34 0.90 1.50 0.65
CD4+ T cells, !109/l 0.3–2.0 0.28 0.70 0.50 0.31
Naïve T cells, !109/l 0.03 0.02 <0.01 <0.01
Effector T cells, !109/l 0.24 0.68 0.24 0.15
CD8+ T cells, !109/l 0.3–2.0 0.24 0.13 0.43 0.31
NK cells, !109/l                                   0.09–0.9 0.33 0.04 0.36 0.41
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A-T at the age of 2 years based on cerebel-
lar ataxia, ocular telangiectasia, recurrent 
upper respiratory tract infections and low 
IgG, absent IgA and slightly increased IgM 
(1.93 g/l;  table 1 ). At the age of 6 years he 
developed progressive lesions on the arms 
and legs. Clinical examination at 8 years 
old showed erythematous atrophic plaques 
on his right hand and left leg associated 
with surface telangiectasia ( fig.  2 ) and 
shallow tender ulcers on his right wrist 
and left foot. At that time, he had mark-
edly decreased CD19+ B cells, low 
CD3+CD4+CD45RA+ naïve T cells and 
low but detectable NK cells in his periph-
eral blood ( table 1 ). On histology, granulo-
matous inflammation was seen in the 
deeper half of the dermis consisting of ep-
ithelioid histiocytes and polynuclear giant 
cells surrounding a necrotic centre. Small 
amounts of mucin were demonstrated in 
the centre of the granuloma. Culture for 
micro-organisms, Ziehl-Neelsen stain and 
periodic acid-Schiff stain were negative. 
The histological and immunohistochemi-
cal features of his granulomas were pub-
lished previously  [27] . Notably, the intra-
lesional CD4+/CD8+ ratio was low (0.28). 
The lesions did not respond to topical or 
intralesional corticosteroids or topical and 
systemic antibiotics. Although some im-
provement was noted with topical tacroli-
mus, the plaques on his limbs persisted. At 
the age of 12, he developed a premalignant 
B cell lymphoma which regressed with 
rituximab. Unfortunately, a year later, he 
was discovered to have nasopharyngeal 
carcinoma and passed away.
 Patient 3 
 Patient 3, a girl of Afghan ancestry, was 
diagnosed as having A-T when she was
1 year old on the basis of a positive family 
history (2 siblings had A-T) and investiga-
tions revealing elevated   -fetoprotein, low 
IgG, deficient IgA and normal IgM ( ta-
ble 1 ). At 7 years old, she presented with 2 
discrete well-demarcated plaques on her 
left lower leg, which appeared after an in-
sect bite. Clinical examination showed a 5 
by 2 cm dusky-red, scaly, well-demarcated 
plaque with central crusting on her left 
lower leg and another similar plaque on 
her right forearm. The lesions were not 
tender. At that time, she had almost ab-
sent CD19+ B cells, very low CD3+CD4+
CD45RA+ naïve T cells and normal NK 
cells in her peripheral blood ( table 1 ).
 Patient 4 
 From the age of 6 months, this Icelan-
dic girl suffered from recurrent otitis me-
dia and pneumonia. When she was 16 
months old, immunological investigations 
revealed IgG and IgA deficiency with nor-
mal IgM ( table 1 ). She was started on im-
munoglobulin substitution and prophy-
laxis for  Pneumocystis jirovecii pneumo-
nia. She developed cerebellar ataxia at 18 
months. At 8 years old, she developed, 
without distinct triggers, erythematous 
indurated plaques on her face, thighs and 
legs. The lesions on her face measured be-
tween 0.5 and 4 cm. They were non-tender, 
not ulcerated, erythematous, slightly in-
durated but not fixed to the underlying 
structures. A biopsy showed granuloma-
tous inflammation. Alcian blue, Ziehl-
Neelsen and periodic acid-Schiff stains 
were normal, and repeated cultures and 
polymerase chain reaction for micro-or-
ganisms were negative. At the time of di-
agnosis of the granulomas, she was found 
to have a significantly decreased number 
of CD19+ B cells, low CD4+ T cells but 
normal NK cells in her peripheral blood 
( table 1 ). Treatment including topical and 
intralesional steroids, topical tacrolimus, 
oral antibiotics, oral antifungal agents and 
etanercept were unsuccessful. With oral 
steroids, the granulomas decreased signif-
icantly but relapsed after withdrawal. 
Control of the granulomas was again ob-
tained with reintroduction of steroids that 
were maintained at low doses.
 Review of the Literature 
 We traced in the literature 17 reported 
A-T patients with cutaneous granulomas 
 [4–13] ( table  2 ). There was a female pre-
ponderance (13 females, 4 males) com-
pared with equal sex distribution in A-T 
patients in general. The age at presentation 
of the cutaneous granulomas ranged from 
1.5 to 31 years. The duration of skin lesions 
before diagnosis varied from 11 months to 
5 years. Interestingly, in 4 of the reported 
patients, the onset of granulomas antedat-
ed the diagnosis and the classical cutane-
ous features of A-T. All patients presented 
in the literature, including ours, had le-
sions on the limbs. The second most com-
mon site was the face, while only a quarter 
of the patients had lesions on their trunk.
 In the reported patients, the granulo-
mas were described to be well-defined ery-
thematous indurated papules and plaques, 
which slowly enlarged and became scaly. 
They were usually small, less than 5 cm in 
diameter, though lesions up to 10 cm were 
reported. Most had central atrophy with 
occasional ulceration and surface telangi-
ectasia. The lesions healed with hyperpig-
mentation. Tenderness was noted in 3 of 
the 17 reported patients whereas 2 of our 4 
patients had significant pain.
 Immunoglobulin levels were measured 
in only 8 of the 17 reported patients. Five 
had IgG deficiency; 3 had normal total 
IgG, although in one IgG2 was low (IgG 





























 Fig. 1. Ulcer on the leg with surrounding 
erythema, atrophy and telangiectasia of 
patient 1. 
 Fig. 2. Erythematous atrophic plaques as-
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2 patients). All 8 patients in whom immu-
noglobulin levels were reported had mark-
edly decreased IgA levels and normal or 
elevated IgM. Only in 1 patient were data 
on B cells, T cells and NK cells available 
 [13] . In this 3-year-old boy, B cell count 
was decreased (0.04  ! 10 9 /l), T cells 
(CD3+) were low (0.30  ! 10 9 /l) with
a marked predominance of T cells
with a memory phenotype (CD3+CD4+
CD45RO+)  [13] , and NK cell numbers 
were normal. Interestingly, T cell rear-
rangement excision circles in this patient 
were extremely low for both CD4+ and 
CD8+ T cells with oligoclonal expansion 
in most peripheral CD4+ and CD8+ T 
cells. Also, the T cell receptor (TCR) rep-
ertoire in the skin biopsy was skewed  [13] .
 No treatment was shown to be effec-
tive. Topical steroids and oral antibiotics 
did not alter the course of the disease 
though topical steroids decreased the ery-
thema and scaling of lesions in 2 patients 
 [4, 5] . Oral steroids in combination with 
oral antibiotics resulted in slow control in 
1 patient in the literature; however, the le-
sions relapsed after cessation of steroids 
 [12] . Similar control and relapse with the 
discontinuation of oral steroids was also 
noted in our fourth patient. Intravenous 
immunoglobulin therapy had no effect in 
3 patients while in another patient, it was 
reported to induce regression of the lesions 
 [7, 11] . Local recurrence and enlargement 
occurred after excision in 1 patient  [5] . 
Paller et al.  [5] proposed a trial of topical 
corticosteroid for granulomas in A-T pa-
tients that are not ulcerated, while applica-
tion of topical mupirocin or non-adherent 
dressings is most appropriate for ulcerated 
lesions. For A-T patients with debilitating 
granulomas, she proposes administration 
of systemic steroids, to be undertaken with 
caution in view of their tendency towards 
progressive sinopulmonary infections.
 Our literature search on the occur-
rence of skin granulomas in other PIDs re-
vealed description of cutaneous granulo-
mas in Nijmegen breakage syndrome 
(NBS)  [14, 15] , severe combined immuno-
deficiency caused by deficiency of recom-
binant activating gene (RAG)  [16] , Arte-
mis  [17] and JAK3  [18] , TAP deficiency 
syndrome  [19–21] , Griscelli syndrome  [22] 
and CVID  [23] ( table 3 ). Three studies on 
skin granulomas were cancelled: 2 studies 
describing lesions in a patient with X-
linked hyper-IgM  [24] and IgA deficiency 
 [25] , because from the decription the le-
sions appeared sarcoid-like not resem-
bling the skin granulomas in A-T, and 1 
study on a man with X-linked agamma-
globulinaemia  [26] because the paper was 
published in 1991 before the  btk  gene anal-
ysis became available and the description 
of the patient did not fit to what is now 
known for X-linked agammaglobulinae-
mia.
 In NBS, a condition caused by a DNA 
repair defect resembling the defect in A-T, 
which is characterized by microcephaly, a 
special face and combined immunodefi-
ciency, 2 patients with skin granulomas 
have been described  [14, 15] . Skin granulo-
mas have been reported also in severe 
combined immunodeficiency caused by 
RAG deficiency  [16] (2 patients), Artemis 
deficiency  [17] (1 patient) or JAK3 defi-
ciency  [18] (1 patient). In Griscelli syn-
drome, characterized by partial pigmen-
tary dilution or albinism, frequent in-
fections and neurological abnormalities, 
defective NK- and T-cell cytotoxicity and 
uncontrolled lymphocyte and macro-
phage activation, 1 patient has been de-
scribed  [22] . In patients with HLA class I 
deficiency (TAP deficiency)  [19–21] and in 
patients with CVID, cutaneous granulo-
mas are reported more frequently. Granu-
lomas in various other organs (lung, liver, 
lymph nodes, gastro-intestinal tract) are a 
well-known feature of the subgroup of 
CVID patients with a defective B cell class 
switch and low T cells  [28] .
 Discussion 
 The principal finding of the current 
study is the observation of non-infectious 
dermal granulomas in A-T patients. A-T is 
a PID associated with defective DNA re-
pair. In B and T cells, this defect causes a 
restricted repertoire of the B cell receptor 
and the TCR  [29] . Approximately 10% of 
A-T patients have a deficiency of IgG and 
IgA and unaffected or even slightly in-
creased IgM levels, which is indicative
of a defective CD4+ Th2-cell-dependent 
switch of B cells in the germinal centre.
All our 4 A-T patients with granulomas 















A-T (classical) N fff N fff N–f N–f N–f N–f N N
Fleck et al. [4], 1986 1 8 f fff ddd
Paller et al. [5], 1991 8
Joshi et al. [6], 1993 1 7 N fff d
Götz et al. [7], 1994 1 13 N fff d ff d
Drolet et al. [8], 1997 1 6.5 N fff N
Murakawa et al. [9], 1998 1 8
Sentürk et al. [10], 1998 1 12 fff f N
Corbisier et al. [11], 1999 1 2 fff f ddd
Mitra et al. [12], 2005 1 4 f fff fff
Folgori et al. [13], 2010 1 3 ff fff N fff ff f ff f N
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had this hyper-IgM phenotype. Indeed, 
switched memory B cells, determined in 2 
of them, were absent [Driessen et al., in 
preparation]. Further, we noticed that by 
the time of diagnosis of the cutaneous 
granulomas in our A-T patients, they all 
had a markedly reduced number of CD19+ 
B cells and CD3+CD4+CD45RA+ naïve T 
cells ( table 1 ). This immunological profile 
is distinct from that observed in our pa-
tients at an earlier stage and also differs 
from that reported in the literature for A-T 
patients without skin granulomas  [30] . In-
terestingly, the same immunological dis-
turbances were mentioned in the A-T pa-
tient with cutaneous granulomas of Fol-
gori et al.  [13] ( table 1 ) and in the patients 
with cutaneous granulomas associated 
with RAG deficiency  [16] and Artemis de-
ficiency  [17] ( table 2 ). CVID patients, par-
ticularly those with B- and T-cell lympho-
penia and reduced switched memory B 
cells, are also more prone to granuloma-
tous disease  [28, 31] . Resolution of cutane-
ous granulomas in RAG deficiency and 
Artemis deficiency have been noted after 
haematopoietic stem cell transplantation 
 [16, 17] .
 In none of the A-T patients with skin 
granulomas was an infective cause dem-
onstrated. Cultures and staining for mi-
cro-organisms in all 17 reported patients 
as well as in all our 4 patients were nega-
tive. In several patients, the granulomas 
developed after minor injuries. The pro-
pensity for granulomas to appear on the 
limbs (trauma-prone area) may be related 
to impaired wound healing and tissue re-
pair in these immunodeficient patients. 
The marked decrease in B cells and naïve 
T cells in our A-T patients coinciding with 
the appearance of the cutaneous granulo-
mas ( table 1 ) suggests that the immunopa-
thology of these skin lesions may be sec-
ondary to impaired B-cell- or T-cell-medi-
ated immune regulation.
 Dermal wound healing is a complex se-
quential process that involves the integra-
tion of chemotaxis of inflammatory cells, 
migration of keratinocytes and remodel-
ling of scar tissue. T cells, B cells and vari-
ous key growth factors and enzymes work 
in synergy to orchestrate the healing pro-
cess  [32] . CD19 is a positive-response regu-
lator of B cells, which plays a critical role in 
wound healing as is shown by the observa-
tion that CD19 deficiency in mice inhibits 
wound healing  [33] . Macrophages exert 
different roles at diverse stages of the re-
pair response, and they orchestrate the 















NBS N–f fff N fff N–f N–f N–f N–f N N
Yoo et al. [14], 2008 1  7 N fff f f
Vogel et al. [15], 2010 1  9 fff fff fff f
RAG deficiency fff fff fff fff fff fff fff fff N N
Schuetz et al. [16], 2008 2  3 fff ff ff fff fff fff f N N
 7 fff ff N ff ff ff low N N N
Artemis deficiency fff fff fff fff fff fff fff fff N N
IJspeert et al. [17], 2011 1  6 N–f ff f ff f f N N N
 Jak3 deficiency f f f N–d ff fff–f
Gregoriou et al. [18], 2008 1  6 fff fff f fff N fff
HLA class I deficiency (TAP deficiency) N N N N N f
Moins-Teisserenc et al. [19], 1999 5 adult N ff dd dd
adult f N d dd
adult ff dd d d
27 f N d dd
36 f f dd dd
Mertens et al. [20], 2000 1 34 ff d
Villa Forte et al. [21], 2008 1 20 N f d N
Griscelli syndrome N N N N N abnormal
Eyer et al. [22], 1998 1  3
Common variable immunodeficiency ff N–fff N–fff ff N–ff N–ff N–ff N N
Ardeniz and Cunningham-Rundles 
[23], 2009 7 14 fff fff fff N
16 fff fff f ff
22 f fff fff fff
27 fff fff fff f
37 fff fff f ff
44 f f N
59 fff fff f f
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natural sequence of repair phases in skin, 
which are essential to restore solid tissue 
homeostasis and integrity after injury  [34] . 
Macrophages are activated in response to 
various cytokines, including interferon-  
(IFN-  )  [35] that is produced by NK cells 
 [36] and by T cells. The crucial role of IFN-
  in the induction of granulomas is illus-
trated by the inability of patients with a de-
fective IFN-  signalling pathway to form 
mature granulomas in response to myco-
bacterial infections  [37] . The importance 
of NK cells is illustrated by the occurrence 
of granulomas in patients with TAP defi-
ciency who lack, by the absence of HLA 
class I molecules, the ability to turn off NK 
cell activity and thus NK-cell-derived 
IFN-  production  [19, 38] . In A-T patients, 
the amount of intracellular IFN-  in NK 
cells is not different from controls  [30] , and 
NK cell numbers were normal in our A-T 
patients and also in patients with RAG de-
ficiency and Artemis deficiency ( table  1 
and  2 ). However, in the patient with JAK3 
deficiency and granulomas, NK cells were 
absent.
 An appropriate on-off T cell response 
requires proliferation of naïve T cells with 
a normal, unrestricted TCR repertoire 
 [39] . In A-T, the TCR repertoire is skewed 
as it was in the patient with skin granulo-
mas reported by Folgori et al.  [13] . Simi-
larly, an abnormal TCR repertoire has 
been reported in the patients with RAG 
deficiency and in patients with CVID who 
display granulomas. Specific CD4+ Th1 
lymphocytes recognize, via their    TCR 
complex, peptide antigens presented by 
macrophages on major histocompatibility 
class II molecules  [40] . Although most T 
cells bear the TCR    complex, a small 
subpopulation of about 5% have a distinct 
TCR composed of   - and   -subunits. For 
non-peptide antigens, as encountered in 
 Mycobacterium infections, IFN-  comes 
mainly from these    T cells which recog-
nize antigens that are not presented in the 
major histocompatibility class II context 
 [41] . T cells bearing    -receptors are pres-
ent in patients with A-T  [42] , NBS, RAG 
deficiency and Artemis deficiency. In the 
patient with JAK3 deficiency and skin 
granulomas, the presence of    T cells was 
not investigated; however,    T cells were 
demonstrated in other patients with this 
defect  [43] . In patients with TAP deficien-
cy,    T cells are elevated, and autoreactive 
NK and    T cells were demonstrated  [38] . 
Both NK cells and    T cells have been re-
ported to be important in the development 
of cutaneous granulomas  [37, 38, 40, 44–
46] .
 IL-10 is a cytokine, derived from Th2 
cells, that inhibits Th1-derived IFN-  pro-
duction  [47, 48] . Thus, whereas granuloma 
induction requires IFN-  , the resolution 
of granulomas needs IL-10. This means 
that appropriate activation of both specific 
Th1 cells and Th2 cells is crucial for an ap-
propriate induction and cessation of a 
granulomatous response.
 We propose that in patients with im-
munodeficiencies like A-T, NBS, deficien-
cies of RAG, Artemis and CVID, macro-
phages cannot function appropriately due 
to the lack of naïve (CD4+CD45RA+) T 
cells with a functional unrestricted TCR 
repertoire on CD4+ Th1 and Th2 cells. 
Whereas NK cells and/or    T cells will 
continue to activate the macrophages in 
the skin, this activation cannot be down-
regulated due to the absence of a counter-
regulatory IL-10 production by a specific 
CD4+ cell population.
 In conclusion, we report that a subset of 
A-T patients with deficiencies of IgG, IgA 
and normal or even increased levels of IgM 
(the so-called hyper-IgM phenotype) is 
more likely to develop cutaneous granulo-
mas. We postulate that the aetiology of 
these granulomas is related to immune 
dysregulation as suggested by a marked re-
duction of peripheral CD19+ B cells, a low 
number of CD3+CD4+CD45RA+ naïve T 
cells in the presence of normal NK cells 
and    T cells.
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